Skip to content
HomeLatest newsBiomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research
 Biomedical scientist Robert Langer headshot

Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.

Robert Langer, Sc.D., an Institute Professor at the Massachusetts Institute of Technology (MIT), has been awarded the 2023 Dr. Paul Janssen Award for Biomedical Research. The annual honor goes to a scientist who’s made a transformational contribution toward improving human health.

And “transformational” describes Langer’s work to a T.

Widely recognized as “the father of controlled drug delivery and tissue engineering,” Langer is being honored for his groundbreaking work in designing novel drug delivery systems that can deliver medications continuously, precisely and at controlled rates over extended periods. His pioneering research into biomedical compounds for drug delivery and tissue engineering has impacted a wide range of medical technologies, including anticancer therapy, vaccine development and gene therapy, among others.

“Early in my career at MIT, a number of professors said the whole idea of doing drug delivery didn’t make sense, that it was wrong,” recalls Langer, whose research lab at MIT is considered the largest biomedical engineering lab in the world. “I believed in what I was doing so I just kept trying.”

Pushing the boundaries of science to change the trajectory of health

Established in 2004 by what is now called Johnson & Johnson Innovative Medicine (formerly known as the Janssen Pharmaceutical Companies of Johnson & Johnson), the prestigious award celebrates dedicated researchers and champions of science whose basic or clinical discoveries have made, or have the potential to make, a measurable impact on human health. The award honors the legacy of “Dr. Paul,” who helped save millions of lives through his contribution to the discovery and development of more than 80 medicines, four of which remain on the World Health Organization’s list of essential medicines today.

Since its inception, the award has recognized 23 scientists, eight of whom have gone on to win the Nobel Prize for the same work. Winners are chosen by an independent selection committee of the world’s most renowned scientists. The award includes a $200,000 cash prize.

“Any award that celebrates science is a good thing—especially if it can inspire young people and people everywhere to see that science can do good things,” says Langer. “Science can make the world a better place.”

To hear from Langer directly and learn more about his work, watch the video below.

DPJA 2024 - Journey of drug delivery - 240201.mp4

Meet more Dr. Paul Janssen Award winners

See how past awardees have left a lasting legacy with their own scientific breakthroughs.

More from Johnson & Johnson

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.